In 2010, Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

BACKGROUND: Used a genetically engineered animal model of ErbB2-driven metastatic breast cancer (the MMTV-neu mouse) to analyze the antitumoral potential of cannabinoids in this particularly aggressive pathology.

You can read the full article here => https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196